SCHEMBL7833167

SCHEMBL7833167

CN1CCC2(CCOc3ccc(N)cc32)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.39
MAPT P10636 4/20 0.38
KDM4E B2RXH2 3/20 0.38
GAA P10253 2/20 0.38
APP P05067 3/20 0.37
BACE1 P56817 3/20 0.37
RAD52 P43351 1/20 0.35
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
OPRK1 P41145 1/20 0.34
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
ADRA2C P18825 1/20 0.34
CHRNB4 P30926 4/20 0.34
CHRNA3 P32297 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6927966 0.87 HTR1D (0.39) MAPTKDM4ERAD52OPRM1OPRD1
SCHEMBL8353721 0.82 HTR1D (0.37) MAPTKDM4EGAAOPRM1OPRD1
SCHEMBL7821093 0.78 KCNH2 (0.41) OPRM1
SCHEMBL7832751 0.78 L3MBTL1 (0.44) MAPTKDM4EGAAAPPOPRD1
SCHEMBL9060832 0.75 KMT2A (0.43) MAPTGAABACE1CHRNB4CHRNA3
SCHEMBL9053722 0.74 RARA (0.48) AKR1B1MAPTKDM4EGAAAPP
SCHEMBL20867781 0.73 KDM4E (0.59) MAPTKDM4EGAARAD52CHRNB4
SCHEMBL6603189 0.72 S1PR5 (0.39)
SCHEMBL6603179 0.71 CYP2D6 (0.39)
SCHEMBL15542586 0.71 MAPT (0.44) AKR1B1MAPTKDM4EGAAAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799226-B1 TETRACYCLIC SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 2001-02-07 EP disclosed
US-5972951-A Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists SMITHKLINE BEECHAM PLC (GB) 1999-10-26 US disclosed
US-5952325-A Tricyclic spiro compounds process for their preparation and their use of 5HT1D receptor antagonists SMITHKLINE BEECHAM PLC (GB) 1999-09-14 US disclosed
EP-0787133-A1 TRICYCLIC SPIRO COMPOUNDS PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1997-08-06 EP disclosed
WO-1996019477-A1 TETRACYCLIC SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-06-27 WO disclosed
WO-1996011934-A1 TRICYCLIC SPIRO COMPOUNDS PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-04-25 WO disclosed